Phoenix, AZ, United States of America

Mark Miglarese

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 3.9

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mark Miglarese

Introduction

Mark Miglarese, an esteemed inventor based in Phoenix, AZ, has made significant strides in the field of biotechnology, amassing a total of eight patents throughout his career. His innovations focus on therapeutic oligonucleotides, addressing various medical challenges associated with diseases through novel methods and compositions.

Latest Patents

Among his latest patents, Mark has developed methods and compositions for oligonucleotides that bind specific targets, including cells and microvesicles derived from various diseases. These oligonucleotides serve important roles in both diagnostic and therapeutic applications. Notable targets of his innovations include PARP1, HIST1H1B, HIST1H1D, NCL, FBL, SFPQ, RPL12, ACTB, HIST1H4A, SSBP1, NONO, H2AFJ, and DDX21. The complexity and potential of these oligonucleotides reflect Mark's commitment to advancing medical research and treatment.

Career Highlights

Mark Miglarese is a key contributor at Caris Science, Inc., where he contributes his expertise and innovative thinking to ongoing projects. His work at the company underscores the intersection of research and practical application, driving forward the possibilities within the biotechnology landscape.

Collaborations

Throughout his career, Mark has collaborated with talented professionals, including David Spetzler and Heather O'Neill. These partnerships enhance his innovative capabilities, enabling the development of impactful solutions in the medical field.

Conclusion

Mark Miglarese is a brilliant inventor whose contributions have shaped the future of therapeutic applications through oligonucleotides. His extensive patent portfolio and collaborative spirit demonstrate his dedication to advancing scientific research and fostering innovation in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…